🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00876850
The purpose of this study was to compare the effects of Vigamox and Cravit ...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00840580
The purpose of the study is to determine whether Moxidex ophthalmic solutio...
Status
Terminated
Location
Contact Alcon Call Center at 1-888-451-3937
Start Date
2007-12
Trial ID
NCT00579020
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00764582
Treatments Being Tested
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Terminated
Location
Paratek Recruiting Site
Start Date
2009-04-04
Trial ID
NCT00865280
Treatments Being Tested
The purpose of this study is to determine if Moxidex otic solution is safe ...
Status
Terminated
Location
Contact Alcon Call Center for Trial Locations
Start Date
2010-02
Trial ID
NCT01071902
Treatments Being Tested
To assess the safety and efficacy of PACK-CXL (photoactivated chromophore f...
Status
Completed
Location
University of Geneva
Start Date
2016-03
Trial ID
NCT02717871
Treatments Being Tested
This is a phase I study evaluating safety and tolerability through the inci...
Status
Completed
Location
Investigacion e Innovacion en Medicina Traslacional
Start Date
2024-02-08
Trial ID
NCT06352541
This is a study to investigate a novel drug candidate for the treatment of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00348348
Treatments Being Tested
This is a study designed to ascertain the effect of PF-04447943 on QT inter...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-06-29
Trial ID
NCT02785770
Treatments Being Tested